Abstract |
Information profiles are presented for the following inorganic chromium compounds: chromic(VI)-acid (1333820), chromic(III)-hydroxide (1308141), chromic(III)-oxide (1308389), chromic(III)-sulfate (10101538), chromic(III)-sulfate (basic) (12336957), chromium-dioxide (12018018), potassium-dichromate(VI) (7778509), lead chromate (7758976), sodium-chromate(VI) (7775113), sodium-dichromate(VI) (10588019), and zinc-yellow-chromate(VI) (37300235). Biological effects of hexavalent chromium in humans included skin ulceration, dermatitis, nasal membrane irritation and ulceration, nasal septal perforation, rhinitis, nosebleed, nephritis, liver damage, epigastric pain, pulmonary congestion and edema, and erosion and discoloration of teeth. Chromium(VI) compounds caused mutations in a variety of systems. Exposure to trivalent chromium in the workplace has caused contact dermatitis and chrome ulcers. Epidemiological studies indicated respiratory carcinogenicity among workers occupationally exposed during chromate production. |